U.S. Banks Stock News

You may think that with a price-to-sales (or "P/S") ratio of 0.3x TH International Limited ( NASDAQ:THCH ) is a stock...

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...

Despite an already strong run, Neogen Corporation ( NASDAQ:NEOG ) shares have been powering on, with a gain of 46% in...

Rackspace Technology, Inc.'s (NASDAQ:RXT) value has fallen 20% in the last week, but insiders who sold US$57k worth of...

Despite the fact that Bumble Inc.'s (NASDAQ:BMBL) value has dropped 14% in the last week insiders who sold US$2.3m...

Key Insights The considerable ownership by retail investors in Chaince Digital Holdings indicates that they...

Riskified Ltd. ( NYSE:RSKD ) is possibly approaching a major achievement in its business, so we would like to shine...

The Morning Bull - US Market Morning Update Monday, Feb, 2 2026 US stock futures are pointing lower this morning, with E-mini S&P 500 contracts down about 0.7% and Nasdaq futures off roughly 1%, as investors react to weaker manufacturing signals and rising borrowing costs abroad. Across Europe, key manufacturing scorecards such as Italy’s and Spain’s PMIs are still below 50, which marks contraction and hints that factories are receiving fewer new orders and facing higher input costs,...

Blackstone Inc. ( NYSE:BX ) has announced that it will be increasing its dividend from last year's comparable payment...

G-III Apparel Group (GIII) is back on investors’ radar after approving a quarterly dividend of US$0.10 per share and raising its fiscal 2026 earnings guidance following stronger-than-expected third quarter results. See our latest analysis for G-III Apparel Group. The dividend decision and upgraded fiscal 2026 guidance come as the share price trades at US$29.35, with a 9.03% 90 day share price return and a 77.69% three year total shareholder return. This suggests momentum has picked up...

Trevi Therapeutics recently reported that key results from its Phase 2b CORAL trial of oral nalbuphine ER for chronic cough in idiopathic pulmonary fibrosis were published in the Journal of the American Medical Association, with safety outcomes broadly consistent with prior studies. The data showed similar discontinuation rates between nalbuphine ER and placebo and fewer serious adverse events in the nalbuphine ER group, underscoring a potentially differentiated safety profile. Next, we’ll...

In January 2026, UWM Holdings CEO Mat Ishbia indirectly sold 1,898,622 shares of Class A common stock for about US$11.14 million under a pre-arranged 10b5-1 trading plan, reducing his overall holdings while leaving his direct ownership unchanged. The scale and timing of these insider sales, against a backdrop of weak mortgage loan volumes, have intensified investor focus on UWM’s leadership intentions and longer-term corporate direction. We’ll now examine how Ishbia’s sizable insider sale...

WisdomTree, Inc. ( NYSE:WT ) has announced that it will pay a dividend of $0.03 per share on the 25th of February. This...

With a price-to-sales (or "P/S") ratio of 10.1x Duos Technologies Group, Inc. ( NASDAQ:DUOT ) may be sending very...

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...

The board of Jacobs Solutions Inc. ( NYSE:J ) has announced that it will be paying its dividend of $0.36 on the 20th of...

Buying a low-cost index fund will get you the average market return. But in any diversified portfolio of stocks, you'll...

Ideally, your overall portfolio should beat the market average. But the main game is to find enough winners to more...

The Charles Schwab Corporation's ( NYSE:SCHW ) dividend will be increasing from last year's payment of the same period...

When a single insider purchases stock, it is typically not a major deal. However, when multiple insiders purchase...

Key Insights Institutions' substantial holdings in Kemper implies that they have significant influence over the...

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...

In recent weeks, VEON announced a collaboration with MindBridge to deploy AI-powered analytics across its global operations and expanded its digital footprint with a new network operations center and BuildX software and AI hub in Uzbekistan, while advancing a U.S. public offering of shares in its Ukrainian subsidiary Kyivstar. Together, these moves highlight VEON’s push to embed artificial intelligence into both its internal controls and customer-facing digital infrastructure across...

UBS recently initiated coverage on Zai Lab (NasdaqGM:ZLAB), highlighting the company’s shift from a China focused commercial model toward a broader global innovation platform and renewed attention on its cancer and immunology pipeline. See our latest analysis for Zai Lab. Despite the UBS coverage putting fresh attention on Zai Lab, the share price has come under pressure, with a 90 day share price return of a 35.88% decline and a 1 year total shareholder return of a 39.37% decline, signaling...